Purple Biotech (PPBT) Intangibles (2017 - 2026)

Purple Biotech (PPBT) has 10 years of Intangibles data on file, last reported at $7.4 million in Q1 2026.

• Intangibles for Q1 2026 came in at $7.4 million, down 73.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.4 million (down 73.57% YoY), and the FY2025 annual result was $7.4 million, down 73.57% from the prior year.
• Intangibles held at $7.4 million in Q1 2026 per PPBT's latest filing, from $7.4 million in the prior quarter.
• Over five years, Intangibles peaked at $28.0 million in Q1 2023 and troughed at $7.4 million in Q4 2025.
• A 5-year average of $23.8 million and a median of $27.8 million in 2024 frame the typical range for Intangibles.
• The sharpest annual moves came in 2023 and 2025: Intangibles jumped 35.58% in 2023, then tumbled 73.57% in 2025.
• A 5-year view of Intangibles shows it stood at $20.7 million in 2022, then jumped by 35.58% to $28.0 million in 2023, then fell by 0.72% to $27.8 million in 2024, then plunged by 73.57% to $7.4 million in 2025, then changed by 0.0% to $7.4 million in 2026.
• Business Quant data shows PPBT's Intangibles at $7.4 million in Q1 2026, $7.4 million in Q4 2025, and $27.8 million in Q3 2025.